4
Changes in Ownership
Lexeo Therapeutics, Inc. Filed Acc 0001415889-25-005110
Chief Development Officer sold 1,486 shares at $4.41 ($6,558)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| See Tai Sandi Chief Development Officer | 2025-02-19 | Sale | −1,486 | $4.41 | $6,558 | 53,889 | D: show line 1 in the form |
| Open-market sales · 1,486 sh · avg $4.41 · $6,558 | |||||||
Loading xslF345X05/form4-02212025_100238.xml…